PULMONOLOGY AND SLEEP MEDICINE
RESEARCH HIGHLIGHTS
Ranked 8 th in the Nation
Pulmonology and sleep medicine specialists at Riley Children’s Health provide advanced, child-focused and family-centered clinical care to children with respiratory and sleep disorders. Our team serves as a specialized medical home that works together with hospital and community-based providers to treat children with chronic respiratory illnesses.
Pulmonology Clinical Trial Volume: 2019 – 2022 125
143 139 146
DIVISION CHIEF James F. Chmiel, MD, MPH, ATSF Professor of Pediatrics, IU School of Medicine > Connect with Dr. Chmiel on Doximity. >
Program distinctions
Riley Children’s is the only facility in the nation to offer all of these procedures for primary ciliary dyskinesia (PCD): ■ Epithelial cell culture prior to electron microscopy ■ Nasal nitric oxide screening test ■ High-speed video microscopy ■ Immunofluorescence staining for ciliary proteins Leading-edge technologies ■ Initiated biologics to reduce asthma exacerbations and improve overall lung function. ■ Fine-tuned disease monitoring using home spirometry to provide care to patients across Indiana. and procedures High-risk asthma Quality improvement initiatives ■ Text-based communication through Twistle platform to assess high-risk asthma patients following discharge ■ Pulmonary hypertension home monitoring program utilizing a mobile device app
2019
2020
2021
2022
Pulmonology Research Funding: 2020 – 2022
■ Eighth leading pediatric pulmonology program in the nation as ranked by U.S. News & World Report
Clinical research
Basic science
23 board certified physicians
$32,277,106
$32,168,763
2020
See full team member list >
■ One of the largest cystic fibrosis programs in the nation; only program in Indiana accredited by the Cystic Fibrosis Foundation
$35,502,573
$27,521,339
2021
$33,423,499
$25,956,286
2022
NOTABLE PUBLICATIONS
■ Home to the nation’s only multidisciplinary program for patients with Alström syndrome
Select pulmonology research studies Funded by the National Institutes of Health ■ Scientific Innovation for Personalized Severe Asthma Management (P01 grant) ■ Clinical Trial to Evaluate Pharmacokinetics and Safety of Slow Release DHEA (Phase IIa) ■ Healthy Lungs Two: Respiratory Outcomes of Full Term Infants with Healthy Lungs (HL2) ■ Vitamin C to Decrease the Effects of Smoking in Pregnancy on Infant Lung Function ■ PARK: Preventing Asthma in High Risk Kids ■ PrecISE: Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network Funded by the Cystic Fibrosis Foundation ■ HERO-2: Home-Reported Outcomes in People with Cystic Fibrosis Taking Highly Effective CFTR Modulator Therapy
Journal of Cystic Fibrosis: December 2022 A Phase I Study Assessing the Safety and Tolerability of Allogeneic Mesenchymal Stem Cell Infusion in
■ One of nine pediatric centers in the nation to be accredited as a Pulmonary Hypertension Center of Comprehensive Care
Adults with Cystic Fibrosis Behavioral Sleep Medicine: December 2022
Specialized programs ■ High-Risk Asthma Program ■ Bronchopulmonary Dysplasia (BPD) Program ■ Interstitial Lung Disease Program ■ Neuromuscular Program Volume and Outcomes: 2019 – 2022 High-Risk Asthma 2019
Our Neuromuscular Program is recognized by the Muscular Dystrophy Association and the Parent Project Muscular Dystrophy
Children’s Sleep and Externalizing Problems: A Day-to-Day Multilevel Modeling Approach American Journal of Perinatology: December 2022 Approaches to Interdisciplinary Care for Infants with Severe Bronchopulmonary Dysplasia: A Survey of the Bronchopulmonary Dysplasia Collaborative The Lancet: January 2022 The Global Prevalence and Ethnic Heterogeneity of Primary Ciliary Dyskinesia Gene Variants: A Genetic Database Analysis
2020
2021
2022
Pulmonology/Sleep Medicine Outpatient Volume: 2019 – 2022
512
305
489
777
Admissions
2019
2020
2021
2022
Riley Pulmonology conducted 6,421 pulmonary function tests and 2,583 sleep studies in 2022.
Readmission Rate .83%
2.42%
1.09%
.92%
New patients 2,866 3,545 Patient visits 13,073 11,165 13,583 16,766 Virtual visits 61 1,749 2,447 2,705 2,267 2,808
Bronchoscopy
571
490
607
742
Refer a patient online
Annual Report 2022 – 2023
317.948.7208
Made with FlippingBook. PDF to flipbook with ease